Evidence map›Paper›PMID 33552605›Full record

ArticleCase reports in obstetrics and gynecology2020

Persistent High-Risk HPV Infection and Molecular Changes Related to the Development of Cervical Cancer.

Pablo Moreno-Acosta, Alfredo Romero-Rojas, Nicolas Vial, Antonio Huertas, Jinneth Acosta, Diana Mayorga, Schyrly Carrillo, Monica Molano, Oscar Gamboa, Martha Cotes and 3 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in obstetrics and gynecology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Pablo Moreno-AcostaResearch Group in Radiobiology Clinical, Molecular and Cellular, National Cancer Institute, Bogota, Colombia.
Alfredo Romero-RojasGroup of Pathology Oncology, National Cancer Institute, Bogota, Colombia.
Nicolas VialDepartment of Radiation Oncology, Institut de cancérologie de la Loire-Lucien Neuwirth, 108 bis, Avenue Albert Raimond, BP 60008, 42271 Saint-Priest en Jarez, France.
Antonio HuertasBiobank, Group of Pathology Oncology, National Cancer Institute, Bogota, Colombia.
Jinneth AcostaPathology Group, National University of Colombia, Bogota, Colombia.
Diana MayorgaResearch Group in Radiobiology Clinical, Molecular and Cellular, National Cancer Institute, Bogota, Colombia.
Schyrly CarrilloResearch Group in Cancer Biology, National Cancer Institute, Bogota, Colombia.
Monica MolanoMicrobiology and Infection Diseases, The Royal Women's Hospital, Melbourne, Australia.
Oscar GamboaUnit of Analysis, National Cancer Institute, Bogota, Colombia.
Martha CotesGroup Area Radiotherapy Oncology, National Cancer Institute, Bogota, Colombia.
Camila CasadiegoGroup Area Radiotherapy Oncology, National Cancer Institute, Bogota, Colombia.
Alexis VallardDepartment of Radiation Oncology, Institut de cancérologie de la Loire-Lucien Neuwirth, 108 bis, Avenue Albert Raimond, BP 60008, 42271 Saint-Priest en Jarez, France.
Nicolas MagneDepartment of Radiation Oncology, Institut de cancérologie de la Loire-Lucien Neuwirth, 108 bis, Avenue Albert Raimond, BP 60008, 42271 Saint-Priest en Jarez, France.ORCID https://orcid.org/0000-0001-6556-063X
Instituto Nacional de Cancerología · COInstitute Cancer De La Loire Lucien Neuwirth · FRRoyal Women's Hospital · AUUniversidad Nacional de Colombia · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article is a preliminary investigational study that is aimed at giving hints about the interesting biomarkers involved in the transition process from low-grade cervix lesion to invasive cervical cancer. Our study focuses on the risk factors and tumour molecular changes in one patient. First in 1986, she was diagnosed a preinvasive cervix lesion. Then, 16 years later, she was diagnosed an invasive cervical cancer. The 2002 diagnosis was a squamous cell carcinoma of the cervix, stage IIIB (FIGO), whereas in 1986, she had been diagnosed a high-grade squamous intraepithelial cervical lesion. Retrospectively, the analysis of samples of preneoplastic lesions and invasive cervical cancer confirmed the histopathological diagnoses and detected the presence of HPV type and HPV-16 variants, as well as the overexpression of proteins such as hTERT, IGF1R

Identifiers

PMID33552605
PMCPMC7845664
OpenAlexW3044287533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.